Respiri Limited Expands US Market Reach with Orb Health Acquisition
Respiri Limited has acquired Orb Health to enhance its presence in the US connected and chronic care market. This strategic move aims to accelerate market commercialization, achieve operational cost savings, and improve service offerings. Nicholas Smedley has transitioned to Non-executive Chairman as part of the company's restructuring. Respiri specializes in medical devices, particularly the wheezo® device for respiratory disorder detection. The company's current market cap is $62.96M, with a year-to-date price performance of -13.46%.
Tip Ranks·
